Luo Yi Li
- Nom: Luo Yi Li
- Native name: 李洛伊
- Nationalité: Chinese
- Genre: Female
- Né•e: septembre 13, 2014
- Age: 11
Drame
| Titre | Note |
|---|---|
Cuo Shi
Chinese Drama, 0000, 0 eps
Wei You Ya
(Rôle Secondaire)
|
0.0
|
Duo Xi Yi Jia Ren
Chinese Drama, 0000, 36 eps
Sai Zhen Zhu
(Rôle Secondaire)
|
0.0
|
The Legend of Rosy Clouds
Chinese Drama, 2026, 36 eps
Zhu Luan
(Invité•e)
|
6.9
|
The Ferryman: 10th Anniversary
Chinese Drama, 2026, 24 eps
{Strang Things - Promise} Xiao Bi Yun
(Invité•e)
|
7.3
|
Love Beyond the Grave
Chinese Drama, 2026, 40 eps
He Si Mu [Young]
(Invité•e)
|
8.1
|
My Dearest Stranger
Chinese Drama, 2026, 13 eps
Yu Xiao [Young]
(Invité•e)
|
7.0
|
Sword Rose
Chinese Drama, 2025, 32 eps
Deng Yan [Child]
(Invité•e)
|
7.8
|
The Litchi Road
Chinese Drama, 2025, 35 eps
Li Xiu Er [Shan De's daughter]
(Rôle Secondaire)
|
7.6
|
Fox Spirit Matchmaker: Love in Pavilion
Chinese Drama, 2025, 36 eps
Jia Lan [Young]
(Invité•e)
|
8.2
|
Northward
Chinese Drama, 2025, 38 eps
Xia Feng Hua [Young]
(Invité•e)
|
8.4
|
Under the Moonlight
Chinese Drama, 2025, 36 eps
Luo Shu Xiang [Child]
(Invité•e)
|
7.6
|
Moonlight Mystique
Chinese Drama, 2025, 40 eps
Bai Shuo [Child]
(Invité•e)
|
8.6
|
Kill Me Love Me
Chinese Drama, 2024, 32 eps
Mei Lin [Child]
(Invité•e)
|
7.9
|
The Princess Royal
Chinese Drama, 2024, 40 eps
Xiao Li Rong
(Rôle Secondaire)
|
8.2
|
Xue Qu Fang
Chinese Drama, 2023, 38 eps
Yan Dou Dou
(Rôle Secondaire)
|
7.4
|
Days With Ambition and Pride
Chinese Drama, 2023, 45 eps
(Rôle Secondaire)
|
0.0
|
Love When the Stars Fall
Chinese Drama, 2023, 40 eps
Zi Wu [Child]
(Invité•e)
|
8.5
|
Our Ordinary Days
Chinese Drama, 2023, 38 eps
Wang Xue Hua [Child]
(Invité•e)
|
7.5
|
Mother's War
Chinese Drama, 2022, 40 eps
Tian You You
(Rôle Secondaire)
|
7.7
|
Talking Bones 2
Chinese Drama, 2022, 30 eps
Tang Tang
(Rôle Secondaire)
|
7.8
|
Da Guo Fei Tian
Chinese Drama, 2021, 36 eps
Fang Fei
(Rôle Secondaire)
|
6.3
|
Qiao Jia De Er Nu
Chinese Drama, 2021, 36 eps
Qiao San Li [Child]
(Invité•e)
|
8.5
|
Ancient Love Poetry
Chinese Drama, 2021, 49 eps
Hou Chi [Child]
(Invité•e)
|
8.5
|
The Glorious Era
Chinese Drama, 2019, 46 eps
(Invité•e)
|
7.8
|
Film
| Titre | Note |
|---|---|
Island Python
Chinese Movie, 2025,
Ni Ni
(Rôle Secondaire)
|
0.0
|
Can You Not Leave Me
Chinese Movie, 2023,
(Invité•e)
|
0.0
|
Ni Shi Wo De Yi Shu Guang
Chinese Movie, 2022,
Sun Miao Miao
(Rôle Secondaire)
|
10.0
|
Programme TV
| Titre | Note |
|---|---|
God! You Are So Tall
Chinese TV Show, 2020, 6 eps
(Ep. 4)
(Invité•e)
|
10.0
|
Trending Articles
Kim Soo Hyun to make first TV appearance after a year-long hiatus
Kim Soo Hyun is set to make his first official public appearance since resuming his activities, marking his full-fledged return to the entertainment industry
Ha Young and Lee Je Hoon's new K-drama issues statement amid the actress's growing controversy
Amid the controversy over actress Ha Young's family history, the team behind the drama 'The Long Shot Trial', in which she plays the lead role, has released a statement
Cha Eun Woo in talks for a new K-drama reportedly set in 'Bon Appetit, Your Majesty' universe
Cha Eun Woo is considering an offer to star in the drama 'Seorabeol Knife' (literal title)
Lee Jong Suk's 'Iseop's Romance' announces female lead
Choi Yun Ji has been confirmed to star alongside Lee Jong Suk in 'Iseop's Romance'
'Our Sticky Love' Ha Young apologizes for lack of awareness about her family history
Actress Ha Young has acknowledged the pro-Japanese activities of her great-grandfather, Ahn Sang Ho, and personally apologized
Director Ahn Pan Seok passes away at 64
Korean media confirms director Ahn Pan Seok's passing. More details inside
'Our Sticky Love' star Ha Young's agency issues statement on family history controversy
Ha Young's agency addresses the controversy surrounding her great-grandfather Ahn Sang Ho and apologizes for its earlier statement
Kim Ji Won makes a generous donation to help children with rare diseases
Actress Kim Ji Won donated 100 million won to Seoul National University Children's Hospital to help child patients with severe, rare, and incurable diseases, as well as to improve the hospital's ward facilities
